|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/58 |
| (11) | Number of the document | 1750688 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05744945.6 |
| Date of filing the European patent application | 2005-04-28 | |
| (97) | Date of publication of the European application | 2007-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2007-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/015113 |
| Date | 2005-04-28 |
| (87) | Number | WO 2005/107727 |
| Date | 2005-11-17 |
| (30) | Number | Date | Country code |
| 837356 | 2004-04-30 | US |
| (72) |
HUANG, Glenn T., US
NIVAGGIOLI, Thierry, US
SPADA, Lon T., US
SUGIMOTO, Hiroshi, JP
BLANDA, Wendy M., US
CHANG, James N., US
OLEJNIK, Orest, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | STEROID INTRAOCULAR IMPLANTS HAVING AN EXTENDED SUSTAINED RELEASE FOR A PERIOD OF GREATER THAN 2 MONTHS |
| STEROID INTRAOCULAR IMPLANTS HAVING AN EXTENDED SUSTAINED RELEASE FOR A PERIOD OF GREATER THAN 2 MONTHS |